Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21)

Journal of Immunology

Volumn 165, Issue 7, 2000, Pages 3839-3848

  Clemenza, L ^a   Isenman, D E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C3D RECEPTOR;

ACIDITY; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BINDING SITE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; DENDRITIC CELL; HUMAN; HUMORAL IMMUNITY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING;

EID: 0034292433     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.7.3839     Document Type: Article

References (46)

1. The role of complement and complement receptors in induction and regulation of immunity
2. In vivo inhibition of the antibody response by complement receptor-specific monoclonal antibody
3. Suppression of the immune response by a soluble complement receptor of B lymphocytes
4. Disruption of the Cr2 locus results in a reduction in B-1a cells and an impaired response to T-dependent antigen
5. Antibody response to T-dependent antigen requires B cell expression of complement receptors
6. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1
7. Regulation of the B cell response to T-dependent antigens by classical complement pathway
8. Impairment of T-cell-dependent B-cells responses and B-1 cell development in CD19-deficient mice
9. Abnormal B lymphocyte development, activation and differentiation in mice that lack or overexpress the CD19 signal transduction molecule
10. Intersection of the complement and immune systems: A signal transduction complex of the B-lymphocyte-containing complement receptor type 2 and CD19
11. The CD19/CR2/TAPA-1 complex of B lymphocytes: Linking natural to acquired immunity
12. Loweriag the threshold for antigen receptor stimulation of B lymphocytes
13. C3d of complement as a molecalar adjuvant: Bridging innate and acquired immunity
14. Amplification of the antibody response by C3b complexed to antigen through an ester link
15. The regulators of complement activation (RCA) gene cluster
16. Mapping of the Epstein-Barr virus and the C3dg binding sites to a common domain on complement receptor type 2
17. Characterization of a complement receptor 2 (CR2, CD21) ligand binding site for C3: An initial model of ligand interaction with two linked short consensus repeat modules
18. Characterization of C3dg binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21)
19. Solution structure of a pair of complement modules by nuclear magnetic resonance
20. X-ray crystal structure of C3d: A C3 fragment and ligand for complement receptor 2
21. Mapping of the C3d-receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement
22. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21)
23. Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2
24. Interaction of iC3b with recombinant isotypic and chimeric forms of CR2
25. Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2)
26. Interactions of human complement component C3 with factor B and complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD1 1b/CD18) involve an acidic sequence at the N terminus of C3 α'-chain
27. Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35)
28. Structure-function analysis of the active sites of complement receptor 1
29. The unactivated form of the first component of human complement, C1
30. Cleavage of C2 by C1s into antigenically distinct fragments C2a and C2b: Demonstration of binding of C2b to C4b
31. The third, fourth and fifth components of human complement: Isolation and biochemical properties
32. Cleavage of C4b by C3b inactivator: Production of a nicked form of C4b, C4b′, as an intermediate cleavage product of C4b by C3b inactivator
33. Human complement C3b inactivator: Isolation, characterization, and demonstration of an absolute requirement for the serum protein β1H for cleavage of C3b and C4b in solution
34. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3
35. Conformational changes accompanying proteolytic cleavage of human complement protein C3b by the regulatory enzyme factor I and its cofactor H
36. An enzymatic method for trace iodination of immunoglobulins and other proteins
37. Site-directed mutagenesis by overlap extension using the polymerase chain reaction
38. Mutagenesis of the Arg-Gly-Asp triplet in human complement component C3 does not abolish binding of iC3b to the leukocyte integrin complement receptor type II1 (CR3, CD11b/CD 18)
39. Expression of a synthetic bovine rhodopsin gene in monkey kidney cells
40. A single arginine to tryptophan interchange at β-chain residue 458 of human complement component C4 accounts for the defect in the classical pathway C5 convertase activity of allotype C4A6: Implications for the location of a C5 binding site in C4
41. A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides
42. Functional properties of complement factor H-related proteins FHR-3 and FHR-4: Binding of the C3d region of C3b and differential regulation by heparin
43. Interaction of vaccinia virus complement control protein with human complement proteins: Factor I-mediated degradation of C3b to iC3bI inactivates the alternative complement pathway
44. Third component of trout complement: cDNA cloning and conservation of functional sites
45. Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides
46. Enhanced molecular mimicry of CEA using photoaffinity linked C3d peptide